GH1 and metabolic syndrome: Other TEAEs related to GH, such as hypothyroidism, injection site pain, adrenal insufficiency, scoliosis, increased intracranial pressure, glucose metabolism abnormalities, dyslipidemia, and fluid retention, occurred very rarely in the Pegpesen group (0-2 cases each).